Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor-F Mautner

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Radiology|February 27, 2009
Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR imagesWenli Cai, Ara Kassarjian, Miriam A Bredella, et al.
Skeletal Radiology|December 8, 2011
Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosisJacob L Jaremko, Peter J MacMahon, Martin Torriani, et al.
BMC Research Notes|July 30, 2018
Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenograftsSusan Fischer-Huchzermeyer, Levan Chikobava, Verena Stahn, et al.
Acta Neuropathologica|December 16, 2003
Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumorsNikola Holtkamp, Victor-F Mautner, Reinhard E Friedrich, et al.
Nuclear Medicine Communications|December 1, 2007
Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1Ralph Buchert, Daniel von Borczyskowski, Florian Wilke, et al.
Oncogene|March 1, 2005
Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acidsGeorge A Mashour, Stephanie N Drissel, Silke Frahm, et al.
Neurobiology of Disease|June 23, 2004
Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patientsSilke Frahm, Victor-F Mautner, Hilde Brems, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumorsNikola Holtkamp, Isis Atallah, Ali-Fuat Okuducu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 19, 2015
Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficitsIvayla Apostolova, Dagmara Niedzielska, Thorsten Derlin, et al.
Plos One|October 24, 2014
Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivoJiang Wei, Marcus Freytag, Yvonne Schober, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Radiology|February 27, 2009
Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR imagesWenli Cai, Ara Kassarjian, Miriam A Bredella, et al.
Skeletal Radiology|December 8, 2011
Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosisJacob L Jaremko, Peter J MacMahon, Martin Torriani, et al.
BMC Research Notes|July 30, 2018
Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenograftsSusan Fischer-Huchzermeyer, Levan Chikobava, Verena Stahn, et al.
Acta Neuropathologica|December 16, 2003
Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumorsNikola Holtkamp, Victor-F Mautner, Reinhard E Friedrich, et al.
Nuclear Medicine Communications|December 1, 2007
Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1Ralph Buchert, Daniel von Borczyskowski, Florian Wilke, et al.
Oncogene|March 1, 2005
Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acidsGeorge A Mashour, Stephanie N Drissel, Silke Frahm, et al.
Neurobiology of Disease|June 23, 2004
Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patientsSilke Frahm, Victor-F Mautner, Hilde Brems, et al.
Neoplasia (New York, N.Y.)|September 6, 2007
MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumorsNikola Holtkamp, Isis Atallah, Ali-Fuat Okuducu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 19, 2015
Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficitsIvayla Apostolova, Dagmara Niedzielska, Thorsten Derlin, et al.
Plos One|October 24, 2014
Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivoJiang Wei, Marcus Freytag, Yvonne Schober, et al.
Pageof 8